arrow
J

Jochen H.M. Prehn

Royal College of Surgeons in Ireland
H指数:78
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advanced 3D patient-derived glioblastoma organoid-immune cell co-cultures reveal preserved MHC-I tumor cell surface expression and tumor cell-driven T-cell dysfunction

高级3D患者源性胶质母细胞瘤类器官-免疫细胞共培养揭示保留的MHC-I肿瘤细胞表面表达及肿瘤细胞驱动的T细胞功能障碍

2026-09-110
OA
Evaluating the NFPp10a/NF5310 glioblastoma model as a faithful avatar for screening tumour microenvironment–targeted therapies

评估NFPp10a/NF5310胶质母细胞瘤模型作为忠实替身用于筛选肿瘤微环境靶向疗法

2026-09-040
OAAI
Cell engulfment defines spatially distinct competitive metabolic niches associated with clinical outcomes in colorectal cancer

细胞吞噬定义了与结直肠癌临床结局相关且空间上不同的竞争性代谢生态位

2026-06-300
OAAI
Spatial analyses implicate high stromal tumour-infiltrating CD8+ lymphocytes as a negative predictive marker for chemotherapy in estrogen receptor-positive breast cancer

空间分析表明,高间质肿瘤浸润性CD8+淋巴细胞可作为雌激素受体阳性乳腺癌化疗的负预测标志物

2026-06-230
OAAI
A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancer

一种基于机器学习的多模态数据融合方法流程,用于贝伐珠单抗治疗转移性结直肠癌的预后风险分析

2026-04-010
OAAI
Biofluid-specific variations in circulating 5′ transfer RNA fragments during ictal and interictal states in experimental temporal lobe epilepsy

实验性颞叶癫痫发作和发作间期状态下循环5′转移RNA片段的生物流体特异性变化

2026-04-010
OAAI
Androgen receptor localisation and protein interactions provide insight into steroid mediated metabolic shifts in endocrine resistant breast cancer

雄激素受体定位和蛋白质相互作用为内分泌抵抗性乳腺癌中类固醇介导的代谢转变提供了见解。

2026-03-170
OAAI
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain

贝伐珠单抗用于染色体不稳定性转移性结直肠癌:德国、爱尔兰和西班牙一种新型精准治疗方法的成本效益分析

2026-02-040
PRE
Serine-arginine protein kinase 1 (SRPK1) is under-expressed in mucinous colorectal cancer, and may mediate resistance to oxaliplatin

粘液性结直肠癌中丝氨酸-精氨酸蛋白激酶1 (SRPK1) 表达下调,并可能介导奥沙利铂耐药性。

2025-10-030
OAAI